Injective (INJ) is currently priced at $3.15, reflecting a 24-hour change of 2.82%. The daily range has been relatively narrow, with a high of $3.17 and a low of $3.04, indicating stable trading conditions.

The trading volume of approximately $33.1 million represents 10.48% of the market cap, suggesting healthy liquidity for traders. Short-term moving averages show a positive trend, with the 8 SMA at $3.09 and increasing by 1.87%, indicating upward momentum in the near term.

The 1-hour RSI stands at 73, suggesting overbought conditions which could lead to a short-term pullback. Conversely, the 7-day RSI at 56 indicates that while the asset is gaining momentum, it is not yet overextended, allowing for potential further upside.

Over the past week, INJ has increased by approximately 11.8%, reflecting strong bullish sentiment, while the 14-day price change shows a modest increase of 3.83%. In the context of a 30-day price change of only 0.49%, this recent rally indicates a shift in market dynamics favoring INJ.

Injective's all-time high of $52.62, reached in March 2024, is significantly above the current price, suggesting substantial upside potential if market conditions remain favorable. However, proximity to the all-time high indicates that resistance levels could be strong if the price approaches that range again.

Given the current technical indicators and the recent price momentum, a Buy rating is warranted. The combination of positive moving averages, manageable RSI levels, and solid volume suggests that INJ has room for growth in the near term, making it an attractive investment opportunity.